Business Wire

Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug ...
Business Wire

Emulate Announces Strategic Collaboration with Johnson & Johnson Innovation to Use Organs-on-Chips Platform to Better Predict Human Response in Drug Development Process

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Emulate, Inc. today announced that it recently formed a research collaboration with Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson ...
MarketWatch

Emulate Launches Brain-Chip R1 to Advance Neurological Drug Development, in Partnership with FUJIFILM Cellular Dynamics

The MarketWatch News Department was not involved in the creation of this content. First-in-class isogenic model of the human neurovascular unit offers unparalleled human relevance for studying ...
Yahoo Finance

EMulate Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating its Paclitaxel ulRFE® Signal to Extend Survival and Slow Tumor Growth in Diffuse Midline Glioma ...

Bellevue, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- EMulate Therapeutics, Inc. (EMTx) announces the acceptance of a publication of its pre-clinical animal model, testing the effect of its ulRFE® ...
Morningstar

Emulate Launches Brain-Chip R1 to Advance Neurological Drug Development, in Partnership with FUJIFILM Cellular Dynamics

First-in-class isogenic model of the human neurovascular unit offers unparalleled human relevance for studying blood-brain barrier drug transport and neuroinflammation. Emulate, Inc., the leading ...